Zepbound™ (tirzepatide)
Experience the life-changing possibilities of Zepbound™, the pioneering GLP-1/GIP medication specially crafted to target weight management with efficiency. With just one weekly dose, this tirzepatide variant for weight reduction offers a hopeful solution for those striving towards improved wellbeing and desired weight.
Self-administered injectable prescription
Helps with weight and blood sugar management
Up to 20.9% reduction in body weight
What is Zepbound™?
Introducing Zepbound™: A Groundbreaking Weight Loss Medication
Zepbound™, the latest version of tirzepatide, has gained approval as an effective weight loss medication. This injectable treatment targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it popular for its dual function. By mimicking the effects of GLP-1, a hormone crucial for regulating glucose and appetite, Zepbound™ helps with weight loss by reducing gastric emptying, promoting a feeling of fullness, and balancing blood sugar levels.
However, Zepbound™ is not a miracle solution and requires lifestyle changes for optimal results. These lifestyle changes include regular exercise and a healthy diet, as simply using weight management medications without these changes may only lead to short-term weight loss.
Here are some benefits of Zepbound™:
Revolutionary dual mechanism: Zepbound™ stands out from traditional weight loss approaches by combining both appetite regulation and metabolic enhancement.
Rapid weight loss results: Within a few weeks, you will notice a significant change in your weight, making Zepbound™ an ideal option for those seeking quick results.
Clinically supported: Scientific research, rigorous studies, and clinical trials have proven tirzepatide's effectiveness for weight loss, with some individuals losing up to 48 lbs.
Introducing Zepbound™: This groundbreaking weight loss medication is now available to help you achieve your weight loss goals.
Zepbound™ for Weight Loss
Zepbound™ How to Use
Dr. Kalou will provide you with detailed instructions on how to properly use Zepbound™, which is available in a variety of dosage strengths. This medication is typically available in pre-filled injection pens for easy use. Here are some basic guidelines to follow when using Zepbound™:
Zepbound™ should be taken once a week at home, with or without food.
The single-dose pen eliminates the need to handle a needle and makes the injection process easier.
Dr. Kaou will help you determine the best injection site, such as the upper arm, lower stomach, or upper thigh. Before injecting, clean the chosen site with an alcohol swab and allow it to dry. It is recommended to rotate injection sites weekly.
Remove the safety cap and place the flat end of the pen against the skin at the injection site.
To start the injection, unlock the pen by turning the lock ring and hold the purple button for 10 seconds.
After use, dispose of the pen in a designated sharps container.
Zepbound™ side effects
Possible effects of tirzepatide for weight loss may be comparable to those of Mounjaro® and other GLP-1s. Side effects that may be associated with Zepbound™ include:
1. Nausea and vomiting
2. Diarrhea or constipation
3. Abdominal pain
4. Mild fatigue and headache
5. Injection site reactions, such as rash, itching, and swelling.
There are also some potential concerns related to tirzepatide, including:
1. Interactions with birth control: Tirzepatide may reduce the effectiveness of oral hormonal birth control. It is recommended to switch to a non-oral form of birth control before beginning Zepbound™.
2. Pancreatitis: There is a risk of pancreatitis associated with Zepbound™.
3. Thyroid tumor: People with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not use tirzepatide due to the potential risk of developing thyroid tumors.
4. Pregnancy and breastfeeding: Zepbound™ should not be used by those planning to become pregnant within the next 3 months or who are currently pregnant or breastfeeding.
If you experience a severe allergic reaction or serious side effects, seek medical attention immediately. Hypoglycemia (low blood sugar) may occur if tirzepatide is taken with insulin or medications that increase insulin levels in the body.
Ongoing research is being conducted regarding the risks of tirzepatide. Currently, there is no long-term safety data available. Continuous monitoring and research will help to establish a more comprehensive understanding of the potential side effects associated with Zepbound™.
Questions Our Patients Ask About Zepbound™
-
The impacts of Zepbound™ typically become noticeable within a couple of weeks, but the exact timeline can differ for each individual.
-
According to the SURMOUNT-1 trial findings, Zepbound™ is among the most potent weight loss medications currently available. Its dual mechanisms of action make it more impactful on weight and blood sugar levels compared to GLP-1 agonist drugs like semaglutide and liraglutide, both of which are FDA-approved for managing weight and sugar levels but sold under different trade names. When comparing tirzepatide with these other GLP-1 medications, it appears to be significantly superior in effectiveness. The results showed that 50% of patients on the 10 mg dose and 57% on the 15 mg dose lost over 20% of their body weight, surpassing the long-term weight loss achieved through procedures like lap-band surgeries. This level of weight loss is also within the typical range seen in long-term outcomes of surgeries like the sleeve gastrectomy.
Our clinic is dedicated to providing accurate information. The information provided is based upon studies published in New England Journal of Medicine, an FDA Press Announcement, the Zepbound™ Official Website, and Lilly Investor News Release.